课题基金 / 基金详情

Elucidating the molecular pathology and development of treatment modalities for ischemic retinopathies

Elucidating the molecular pathology and development of treatment modalities for ischemic retinopathies
阐明缺血性视网膜病的分子病理学和治疗方式的发展
批准号:
20390448
负责人:
TERASAKI Hiroko
金额:
$12.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

TERASAKI Hiroko的其他基金

相似基金

相关文献

中文摘要
翻译
血管内皮生长因子的眼内动力学在包括视网膜分支静脉阻塞在内的缺血性视网膜病变的发病机制中起着关键作用。事实证明,长期抑制眼内血管内皮生长因子水平对维持视力很重要。在用小鼠进行的实验中,外周循环中的炎性细胞的作用被证明不是视网膜新生血管形成的关键。同时,玻璃体中的巨噬细胞在这方面可能是重要的。
英文摘要
The intraocular dynamics of VEGF plays a critical role in the pathogenesis of ischemic retinopathy including branch retinal vein occlusion. The long term suppression of intraocular VEGF levels proved important to maintain vision. In the experiments using mice, the role of inflammatory cells in the peripheral circulation was shown not to be essential for the formation of retinal neovascularization. Meanwhile, macrophages in the vitreous may be important in this aspect.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-thera for rheumatoid arthritis.
类风湿性关节炎的抗 TNF-Thera 期间继发于视网膜分支静脉阻塞的黄斑水肿的消退。
DOI: --
发表时间: 2010
期刊: Clin Ophthalmol
影响因子: 2.2
作者: [Sakamoto T, Sheu SJ, Arimura N, Sameshima S, Shimura M, Uemura A, Kawano H, Wu TT, Kubota T, Sohma R, Noda Y., Kachi S]
通讯作者: Kachi S
Blimpl suppresses Chx10 expression in differentiating retinal photorecept or precursors to ensure proper hotorece for development.
Bimplimpl 抑制 Chx10 在分化视网膜光感受器或前体细胞中的表达,以确保适当的光感受器发育。
DOI: --
发表时间: 2011
期刊: J Neurosci
影响因子: 5.3
作者: [Takabayashi T, et al., Katoh K]
通讯作者: Katoh K
Macular function and photopic negative response after single injection of intravitreal bevacizumab for myopic neovascularization
单次玻璃体内注射贝伐单抗治疗近视新生血管后的黄斑功能和明视阴性反应
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Endoh H, Hida S, Hayashi Y, Ohashi S, Takahashi A]
通讯作者: Takahashi A
DOI: 10.1167/iovs.08-2863
发表时间: 2009-03-01
期刊: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
影响因子: 4.4
作者: [Kondo, Mineo, Sakai, Takao, Terasaki, Hiroko]
通讯作者: Terasaki, Hiroko
83
    Investigation of pathogenegs and new treatment for developmental, age-related and inherited chorioretinal diaasse
    • 批准号:
      18390466
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.5万
    • 财政年份:
      2006
    • 负责人:
      TERASAKI Hiroko
    • 依托单位:
    New treatment and functional analysis of age related macular diseases
    • 批准号:
      16390497
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.87万
    • 财政年份:
      2004
    • 负责人:
      TERASAKI Hiroko
    • 依托单位:
    Pathophysiology of vitreous and new therapeutic modality
    • 批准号:
      14370557
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.48万
    • 财政年份:
      2002
    • 负责人:
      TERASAKI Hiroko
    • 依托单位:
    Study for Pathophysiology in Vitreo-retinal surgery
    • 批准号:
      12470361
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.81万
    • 财政年份:
      2000
    • 负责人:
      TERASAKI Hiroko
    • 依托单位:
    海外基金